Les 10 concurrents getthewordout.com.au les plus visités

prnewswire.co.uk

Corporate Social Responsibility

pressat.co.uk

It might have...

kingnewswire.com

Contact to king Newswire to get the Press release service

newswire.ca

Economic News, Trends, Analysis

newmediawire.com

LOS ANGELES, CA - January 9, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) was among the medical device companies highlighted in a Jan. 8 report by Modern Healthcare by Lauren Dubinsky that outlined FDA clearances and approvals across the medical device sector. HeartBeam’s 12-lead electrocardiogram synthesis software was cleared Dec. 8 to assess arrhythmias by converting heart signal data captured from 3 dimensions using the company’s portable, non-invasive recorder into a standard 12-lead ECG format suitable for remote clinical review. HeartBeam recently reinforced its technology leadership with recognition as a Global IP and Technology Leader in Portable Cardiac Diagnostics, ranking second worldwide and trailing only GE Healthcare, in 12-lead ECG innovation among 243 companies evaluated in PatentVest’s “Total Cardiac Intelligence” report, according to an InvestorBrandNetwork report. The ranking reflects the strength of its intellectual-property foundation, with 82 global patent publications across 15 patent families supporting its three-dimensional cardiac signal capture and 12-lead ECG synthesis architecture, underscoring the company’s growing influence in next-generation remote cardiac monitoring. To learn more about Heartbeam’s Portable ECG Technology, visit https://ibn.fm/pfPB1 About HeartBeam, Inc. HeartBeam, Inc. is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first-ever cable-free device capable of collecting ECG signals in 3D, from three non-coplanar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health manageme

pressreach.com

TORONTO, May 28, 2026 - Mayfair Gold Corp. ("Mayfair", "Mayfair Gold", or the "Company") (TSXV:MFG) (NYSE American: MINE) is pleased to announce the

diffusionpr.com

From smart homes and intelligent energy systems to sustainable mobility and personalised wellness, Purpose Technology is transforming how we, our families, and our communities live, move, and care for the world around them.

sandpipercomms.com

Innovative drugs and devices are being made more accessible in general across the region, while public healthcare coverage differs substantially from country to country, giving rise to a range of hybrid, multi-payment systems and different types of public-private partnerships. This poses great opportunity, but also challenges, for drug and device manufacturers, as well as healthcare providers – and especially healthcare communicators.

starlightpr1.com

Promote your music with expert PR campaigns. Get SoundCloud plays, radio exposure, press coverage & sell your music on iTunes. Reach fans worldwide today.